Liver cancer is one of the deadliest cancers, ranking as the third-leading cause of cancer deaths. It is often found too late, when treatment options are limited.
A new study by Yatendra Singh, a researcher at the University of Mississippi, and Arun Kumar Jajoriya, from Suresh Gyan Vihar University in India, brings hope. They found that cardiac glycosides, plant-based compounds used in heart medications, may help treat liver cancer.
These compounds show promise against hepatocellular carcinoma, the most common form of liver cancer, which mostly affects men and people with long-term liver diseases, such as cirrhosis.
Their findings were published in the journal Pharmacological Research—Natural Products.
No specific quote available in the given text.
Author's summary: A heart drug may help treat liver cancer.